70. Tamura A, Naono S, Torigo K, Hino M, Maeda S, Shinozaki K, et al. Gender differences in symptoms during 60-second balloon occlusion of the coronary artery. Am J Cardiol. 2013; 111:1751–4.
71. Main C, Knight B, Moxham T, Gabriel Sánchez R, Sánchez Gómez LM, Roque´ I Figuls M, et al. Hormone therapy for preventing cardiovascular disease in postmenopausal women. Cochrane Database Syst Rev. 2013; 4.
72. Udell JA, Lu H, Redelmeier DA. Long term cardiovascular risk in women prescribed fertility therapy. J Am Coll Cardiol. 2013; 62:1704–12. F. Marın et al / Rev ESP Cardiol. 2014; 67(2):120–126 125.
73. Darby SC, Ewertz M, McGale P, Bennet AM, Blom-Goldman U, Brønnum D, et al. Risk of ischemic heart disease in women after radiotherapy for breast cancer. N Eng J Med. 2013; 368:987–98.
74. Hermida RC, Ayala DE, Mojón A, Fontao MJ, Chayan L, Fernández JR. Differences between men and women in ambulatory blood pressure thresholds for diagnosis of hypertension based on cardiovascular outcomes. Chronobiol Int. 2013; 30:221–32.
75. Diegeler A, Bo¨rgermann J, Kappert U, Breuer M, Bo¨ning A, Ursulescu A, et al; GOPCABE Study Group. Off-pump versus on-pump coronary-artery bypass grafting in elderly patients. N Engl J Med. 2013; 368:1189–98.
76. Houlind K, Kjeldsen BJ, Madsen SN, Rasmussen BS, Holme SJ, Nielsen PH, et al; DOORS Study Group. On-pump versus off-pump coronary artery bypass surgery in elderly patients: results from the Danish on-pump versus off-pump randomization study. Circulation. 2012; 125:2431–9.
77. Kutcher MA, Brennan JM, Rao SV, Dai D, Anstrom KJ, Mustafa N, et al. Comparative effectiveness of drug-eluting stents on long-term outcomes in elderly patients treated for in-stent restenosis: A report from the National Cardiovascular Data Registry. Catheter Cardiovasc Interv. 2013; 82:16–29.
78. Patel MR, Marso SP, Dai D, Anstrom KJ, Shunk KA, and Curtus JP, et al. Comparative effectiveness of drug-eluting versus bare-metal stents in elderly patients undergoing revascularization of chronic total coronary occlusions: results from the National Cardiovascular Data Registry, 2005-2008. JACC Cardiovasc Interv. 2012; 5:1054–61.
79. Bayes de Luna A, Elosua R. Muerte súbita. Rev Esp Cardiol. 2012; 65:1039–52.
80. Loma-Osorio P, Aboal J, Sanz M, Caballero A, Vila M, Lorente V, et al. Características clínicas, pronostico vital y funcional de los pacientes supervivientes a una muerte su´ bita extrahospitalaria ingresados en cinco unidades de cuidados intensivos cardiológicos. Rev Esp Cardiol. 2013; 66:623 8.
81. Escorial Hernández V, Meizoso Latova T, Alday Muñoz E, Lo´ pez de Sa´ E, Guerrero JE, López-Sendon J. Pronostico de los pacientes ingresados en la unidad coronaria o de cuidados intensivos tras un episodio de muerte subita extrahospitalaria. Rev ESP Cardiol. 2001; 54:832–7.
82. Nolan JP, Morley PT, Vanden Hoek TL, Hickey RW, Kloeck WG, Billi J, et al. Therapeutic hypothermia after cardiac arrest: an advisory statement by the advanced life support task force of the International Liaison Committee on Resuscitation. Circulation. 2003; 108:118–21.
83. López-de-SaE, ReyJR, ArmadaE, Salinas P, Viana-Tejedor, Espinosa-García S, et al. Hypothermia in comatose survivors from out-of-hospital cardiac arrest: pilot trial comparing 2 levels of target temperature. Circulation. 2012; 126:2826–33.
84. Hagihara A, Hasegawa M, Abe T, Nagata T, Wakata Y, Miyazaki S. Prehospital epinephrine use and survival among patients with out-of-hospital cardiac arrest. JAMA. 2012; 307:1161–8.
85. Mentzelopoulos SD, Malachias S, Chamos C, Konstantopoulos D, Ntaidou T, Papastylianou A, et al. Vasopressin, steroids, and epinephrine and neurologically favorable survival after in-hospital cardiac arrest: a randomized clinical trial. JAMA. 2013; 310:270–9.
86. Rubertsson S, Silfverstolpe J, Rehn L, Nyman T, Lichtveld R, Boomars R, et al. The Study Protocol for the LINC (LUCAS in Cardiac Arrest) Study: a study comparing conventional adult out-of-hospital cardiopulmonary resuscitation with a concept with mechanical chest compressions and simultaneous defibrillation. Scand J Trauma Resusc Emerg Med. 2013; 21:5.
87. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, Hausleiter J, et al. Intraaortic balloon support for myocardial infarction with cardiogenic shock. N Engl J Med. 2012; 367:1287–96.
88. Rekhraj S, Noman A. Intraaortic balloon support for cardiogenic shock. N Engl J Med. 2013; 368:80–1.
89. Thiele H, Zeymer U, Neumann FJ, Ferenc M, Olbrich HG, and Hausleiter J, et al. Intraaortic balloon counterpulsation in acute myocardial infarction complicated by cardiogenic shock (IABP-SHOCK II): final 12 month results of a randomised, open-label trial. Lancet. 2013; 382:1638–45.
90. Sjauw KD, Engstro¨m AE, Vis MM, Van der Schaaf RJ, Baan Jr J, Koch KT, et al. A systematic review and meta-analysis of intra-aortic balloon pump therapy in ST-elevation myocardial infarction: should we change the guidelines? Eur Heart J. 2009; 30:459–68.
91. Unverzagt S, Machemer M, Solms A, Thiele H, Burkhoff D, Seyfarth M, et al. Intra-aortic balloon pump counterpulsation (IABP) for myocardial infarction complicated by cardiogenic shock. Cochrane Database Syst Rev. 2011; 7.
92. Bahekar A, Singh M, Singh S, Ahmad K, Khosla S, Arora R. Cardiovascular outcomes using intra-aortic balloon pump in high-risk acute myocardial infarction with or without cardiogenic shock: a meta-analysis. J Cardiovasc Pharmacol Ther. 2012; 17:44–56.
93. Prondzinsky R, Unverzagt S, Russ M, Lemm H, Swyter M, Wegener N, et al. Hemodynamic effects of intra-aortic balloon counterpulsation in patients with acute myocardial infarction complicated by cardiogenic shock: the prospective, randomized IABP shock trial. Shock. 2012; 37:378–84.
94. Werdan K, Gielen S, Ebelt H, Hochman JS. Mechanical circulatory support in cardiogenic shock. Eur Heart J. 2013.
95. Ariza-Sole´ A, Sánchez-Salado JC, Lorente-Tordera V, Gonzalez-Costello J, Miralles- Cassina A, Cequier-Fillat A. Asistencia ventricular con membrana de oxigenación extracorpórea: una nueva alternativa al rescate del shock cardiogenico refractario. Rev ESP Cardiol. 2013; 66:501–3.
96. F. 126 Marın et al / Rev ESP Cardiol. 2014; 67 (2):120–126.
97. Descalzo M, Leta R, Rossello X, Alomar X, Carreras F, Pons-Llado G. Enfermedad coronaria subclínica por tomografía computarizada multidetector en población asintomática estratificada por nivel de riesgo coronario. Rev ESP Cardiol. 2013; 66:504–5.
98. Mazimba S, Grant N, Parikh A, Patel T, Dahale B, Franco Z, et al. Comparison of the 2006 and 2010 cardiac CT appropriateness criteria in a real-world setting. J Am Coll Radiol. 2012; 9:630–4.
99. Romeo F, Leo R, Clementi F, Razzini C, Borzi M, Martuscelli E, et al. Multislice computed tomography in an asymptomatic high-risk population. Am J Cardiol. 2007; 99:325–8.
100. Cho I, Chang HJ, Sung JM, Pencina MJ, Lin FY, Dunning AM, et al. Coronary computed tomographic angiography and risk of all-cause mortality and nonfatal myocardial infarction in subjects without chest pain syndrome from the CONFIRM Registry (coronary CT angiography evaluation for clinical outcomes: an international multicenter registry). Circulation. 2012; 126:304–13.
101. Ahmadi N, Tsimikas S, Hajsadeghi F, Saeed A, Nabavi V, Bevinal MA, et al. Relation of oxidative biomarkers, vascular dysfunction, and progression of coronary artery calcium. Am J Cardiol. 2010; 105:459–66.
102. Villines TC, Hulten EA, Shaw LJ, Goyal M, Dunning A, Achenbach S, et al. Prevalence and severity of coronary artery disease and adverse events among symptomatic patients with coronary artery calcification scores of zero undergoing coronary computed tomography angiography: results from the CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter) registry. J Am Coll Cardiol. 2011; 58: 2533–40.
103. Min JK, Dunning A, Lin FY, Achenbach S, Al-Mallah M, Budoff MJ, et al. Age- and sex-related differences in all-cause mortality risk based on coronary computed tomography angiography findings results from the International Multicenter CONFIRM (Coronary CT Angiography Evaluation for Clinical Outcomes: An International Multicenter Registry) of 23,854 patients without known coronary artery disease. J Am Coll Cardiol. 2011; 58:849–60. Rev Esp Cardiol. 2013; 66(11):916.